首页|阿替普酶静脉溶栓后序贯替罗非班治疗急性缺血性脑卒中患者的效果观察

阿替普酶静脉溶栓后序贯替罗非班治疗急性缺血性脑卒中患者的效果观察

扫码查看
目的 观察阿替普酶静脉溶栓后序贯替罗非班治疗急性缺血性脑卒中(AIS)患者的临床效果.方法 选择2021年1月-2023年12月江苏省昆山市第一人民医院收治的急性缺血性脑卒中患者60例,按随机数字表法分两组,各30例.对照组常规阿替普酶溶栓治疗,研究组阿替普酶静脉溶栓后序贯替罗非班治疗.比较两组患者治疗后各项神经功能缺损评分、多普勒超声脑血流图、日常生活能力、自我护理能力、运动功能及生活质量评分,评价患者治疗效果.结果 治疗前,两组患者各项神经功能缺损评分、经颅多普勒超声(TCD)脉动指数、阻力指数、收缩期最大血流速度、舒张末期血流速度、平均血流速度、日常生活能力、自我护理能力、运动功能及生活质量评分差异均无统计学意义(P>0.05);治疗后,与对照组比较,研究组各项神经功能缺损评分、TCD脉动指数、阻力指数均降低,收缩期最大血流速度、舒张末期血流速度、平均血流速度、日常生活能力、自我护理能力、运动功能及生活质量评分均升高(P<0.05).与对照组比较,研究组总有效率更高,差异有统计学意义(P<0.05).结论 AIS患者以阿替普酶静脉溶栓后序贯替罗非班治疗,可明显地减轻患者神经功能缺损的严重程度,改善脑动力学指标,提升患者日常生活能力、自我护理能力及运动功能,改善患者生活质量,值得临床推广.
Effects of sequential tirofiban on patients with acute ischemic stroke(AIS)after alteplase intravenous thrombolysis
Objective To observe the effects of sequential tirofiban treatment following alteplase intrave-nous thrombolysis in patients with acute ischemic stroke(AIS).Methods 60 patients with AIS admitted to Kunshan First People's Hospital from January 2021 to December 2023 were randomly divided into 2 groups of 30 cases each using the random number table method.The control group received standard alte-plase thrombolysis,while the study group received sequential tirofiban treatment after alteplase intrave-nous thrombolysis.The neurological deficit scores,doppler ultrasound cerebral blood flow,daily living a-bility,self-care ability,motor function and quality of life scores were compared before and after the treat-ment in both groups to evaluate the treatment effect.Results Before the treatment,compared with con-trol group,there were no significant differences in the scores of neurologic impairment,TCD pulsatility index,resistance index,maximum systolic velocity,end-diastolic velocity,average velocity,ability of dai-ly living,self-care,motor function and quality of life in study group(P>0.05).After thetreatment,the neurological deficit scores,pulsatility index and resistance index in study group were significantly lower than those in control group,while the systolic peak flow velocity,end-diastolic flow velocity,mean flow velocity,daily living ability,self-care ability,motor function and quality of life scores were significantly higher(P<0.05).The study group also had a higher overall effective rate compared to the control group,with a statistically significant difference(P<0.05).Conclusion Sequential tirofiban treatment after alte-plase intravenous thrombolysis in AIS patients can significantly reduce the severity of neurological deficits,improve hemodynamic indicators,enhance daily living abilities,self-care abilities,and motor functions,and improve the quality of life,making it worthy of clinical promotion.

tirofibanalteplaseacute ischemic stroke(AIS)neurological deficit scoreTranscranial doppler ultrasound

任洁明、张炎、杨华

展开 >

江苏省昆山市第一人民医院神经内科,江苏 昆山 215300

阿替普酶 替罗非班 急性缺血性脑卒中 神经功能缺损评分 经颅多普勒超声

江苏省自然科学基金面上项目

BK20201199

2024

新疆医科大学学报
新疆医科大学

新疆医科大学学报

CSTPCD
影响因子:0.76
ISSN:1009-5551
年,卷(期):2024.47(9)